News & Updates
Filter by Specialty:
Ribociclib plus letrozole improves OS in hormone receptor–positive, HER2-negative advanced breast cancer
A combined regimen of ribociclib plus letrozole as first-line treatment provides a statistically significant and clinically meaningful overall survival (OS) benefit vs placebo plus letrozole in postmenopausal patients with hormone receptor–positive and HER2-negative advanced breast cancer (BC), results of the phase III MONALEESA-2 study have shown.
Ribociclib plus letrozole improves OS in hormone receptor–positive, HER2-negative advanced breast cancer
27 Sep 2021Aggressive hydration averts contrast-induced AKI in STEMI patients undergoing PCI
Perioperative aggressive hydration appears to be better than general hydration at preventing contrast-induced acute kidney injury (AKI) among patients with myocardial infarction with ST-segment elevation (STEMI) undergoing primary percutaneous coronary intervention (PCI), a study has found.
Aggressive hydration averts contrast-induced AKI in STEMI patients undergoing PCI
26 Sep 2021Educational intervention improves lung function, quality of life, inflammatory profile in asthmatics
An educational intervention for proper inhaled corticosteroid use helps improve lung function, quality of life, and control of inflammation among asthma patients, a recent study has found.